Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis

Completed · Phase 4

Conditions studied: Granulomatosis With Polyangiitis, Microscopic Polyangiitis

In brief

The purpose of this pilot study is to test whether an 8-week course of glucocorticoids, combined with rituximab, is effective in treating ANCA-associated vasculitis.

Key facts

Study ID
NCT02169219
Run by
Massachusetts General Hospital
People needed
20
Starts
2014-06-01
Expected to finish
2017-11-01
Last updated by the study team
2021-06-25

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.